First Time Loading...

Y-mAbs Therapeutics Inc
NASDAQ:YMAB

Watchlist Manager
Y-mAbs Therapeutics Inc Logo
Y-mAbs Therapeutics Inc
NASDAQ:YMAB
Watchlist
Price: 12.07 USD -0.25% Market Closed
Updated: Jun 4, 2024

Y-mAbs Therapeutics Inc
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Y-mAbs Therapeutics Inc
Common Shares Outstanding Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
Y-mAbs Therapeutics Inc
NASDAQ:YMAB
Common Shares Outstanding
$43.9m
CAGR 3-Years
0%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Common Shares Outstanding
$1.8B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
1%
Gilead Sciences Inc
NASDAQ:GILD
Common Shares Outstanding
$1.2B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
-2%
Amgen Inc
NASDAQ:AMGN
Common Shares Outstanding
$536.4m
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
-3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Common Shares Outstanding
$258.3m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
1%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Common Shares Outstanding
$110.2m
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
1%

See Also

What is Y-mAbs Therapeutics Inc's Common Shares Outstanding?
Common Shares Outstanding
43.9m USD

Based on the financial report for Mar 31, 2024, Y-mAbs Therapeutics Inc's Common Shares Outstanding amounts to 43.9m USD.

What is Y-mAbs Therapeutics Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
5%

Over the last year, the Common Shares Outstanding growth was 0%.